Literature DB >> 16946504

Characterization of anti-neurodegenerative effects of Polygala tenuifolia in Abeta(25-35)-treated cortical neurons.

Rie Naito1, Chihiro Tohda.   

Abstract

Although Polygala tenuifolia WILLD (PT) was classically mentioned as an anti-dementia drug in Chinese and Japanese traditional medicine, basic research showed only enhancement of the cholinergic function. In Alzheimer's disease, neuritic atrophy and synaptic loss occur prior to neuronal death event, and may be the first trigger of the memory impairment. Therefore, we studied effects of Polygala tenuifolia WILLD (PT) on Abeta(25-35)-induced neuronal damage using rat cortical neurons for characterization of activities of PT under Abeta-induced neuronal damage. Treatment with the water extract of PT enhanced axonal length dose-dependently after Abeta(25-35)-induced axonal atrophy. However, dendritic atrophy and synaptic loss induced by Abeta(25-35) were not recovered by treatment with PT extract. In contrast, Abeta(25-35)-induced cell damage was completely inhibited by PT extract. By characterization of PT effects on neuronal morphological plasticity and cell damage, usefulness as well as an insufficiency of PT as an anti-dementia drug was clarified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946504     DOI: 10.1248/bpb.29.1892

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  16 in total

1.  Polygalasaponin XXXII, a triterpenoid saponin from Polygalae Radix, attenuates scopolamine-induced cognitive impairments in mice.

Authors:  Heng Zhou; Wei Xue; Shi-Feng Chu; Zhen-Zhen Wang; Chuang-Jun Li; Yi-Na Jiang; Lin-Ming Luo; Piao Luo; Gang Li; Dong-Ming Zhang; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

2.  Polygalasaponin XXXII from Polygala tenuifolia root improves hippocampal-dependent learning and memory.

Authors:  Wei Xue; Jin-feng Hu; Yu-he Yuan; Jian-dong Sun; Bo-yu Li; Dong-ming Zhang; Chuang-jun Li; Nai-hong Chen
Journal:  Acta Pharmacol Sin       Date:  2009-08-17       Impact factor: 6.150

3.  Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues.

Authors:  M Obulesu; Dowlathabad Muralidhara Rao
Journal:  J Neurosci Rural Pract       Date:  2011-01

4.  Traditional chinese medicine for senile dementia.

Authors:  Zhihong Lin; Jie Gu; Jin Xiu; Tingyan Mi; Jie Dong; Jyoti Kumar Tiwari
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-25       Impact factor: 2.629

5.  Traditional used Plants against Cognitive Decline and Alzheimer Disease.

Authors:  Gunter Peter Eckert
Journal:  Front Pharmacol       Date:  2010-12-08       Impact factor: 5.810

6.  Systematic review on the efficacy and safety of herbal medicines for vascular dementia.

Authors:  Sui Cheung Man; Kam Wa Chan; Jia-Hong Lu; Siva Sundara Kumar Durairajan; Liang-Feng Liu; Min Li
Journal:  Evid Based Complement Alternat Med       Date:  2011-10-20       Impact factor: 2.629

7.  The Aqueous Extract of Rhizome of Gastrodia elata Protected Drosophila and PC12 Cells against Beta-Amyloid-Induced Neurotoxicity.

Authors:  Chun-Fai Ng; Chun-Hay Ko; Chi-Man Koon; Jia-Wen Xian; Ping-Chung Leung; Kwok-Pui Fung; Ho Yin Edwin Chan; Clara Bik-San Lau
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

8.  Effects of sinapic Acid of 4 vessel occlusion model-induced ischemia and cognitive impairments in the rat.

Authors:  Young-Ock Kim; Sang-Won Lee; Myung-Sook Oh; Hee Jae Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

9.  Kihi-to, a herbal traditional medicine, improves Abeta(25-35)-induced memory impairment and losses of neurites and synapses.

Authors:  Chihiro Tohda; Rie Naito; Eri Joyashiki
Journal:  BMC Complement Altern Med       Date:  2008-08-16       Impact factor: 3.659

10.  New Treatment for Alzheimer's Disease, Kamikihito, Reverses Amyloid-β-Induced Progression of Tau Phosphorylation and Axonal Atrophy.

Authors:  Hidetoshi Watari; Yutaka Shimada; Chihiro Tohda
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.